Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 1103.16% year-over-year, with the annual reading at $1.1 million for FY2025, 1103.16% up from the prior year.
  • Asset Writedowns and Impairment hit $1.1 million in Q4 2025 for Rapid Micro Biosystems, up from -$216000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.1 million in Q4 2025 to a low of -$216000.0 in Q2 2025.
  • Historically, Asset Writedowns and Impairment has averaged $147272.7 across 5 years, with a median of $49000.0 in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 2733.33% in 2022 and later plummeted 2260.0% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $16000.0 in 2021, then surged by 568.75% to $107000.0 in 2022, then plummeted by 68.22% to $34000.0 in 2023, then tumbled by 70.59% to $10000.0 in 2024, then soared by 11140.0% to $1.1 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for RPID at $1.1 million in Q4 2025, -$216000.0 in Q2 2025, and $235000.0 in Q1 2025.